| Primary |
| Psoriasis |
63.6% |
| Product Used For Unknown Indication |
16.5% |
| Psoriatic Arthropathy |
4.0% |
| Hypertension |
3.3% |
| Diabetes Mellitus |
1.8% |
| Ill-defined Disorder |
1.6% |
| Prophylaxis |
1.4% |
| Depression |
1.4% |
| Pain |
1.2% |
| Pustular Psoriasis |
0.8% |
| Drug Use For Unknown Indication |
0.7% |
| Crohn's Disease |
0.6% |
| Anxiety |
0.5% |
| Hyperlipidaemia |
0.5% |
| Hypothyroidism |
0.4% |
| Blood Cholesterol Increased |
0.4% |
| Pruritus |
0.4% |
| Blood Cholesterol |
0.3% |
| Arthritis |
0.3% |
| Asthma |
0.3% |
|
| Psoriasis |
15.8% |
| Myocardial Infarction |
12.8% |
| Pneumonia |
9.6% |
| Cerebrovascular Accident |
5.5% |
| Cellulitis |
4.6% |
| Psoriatic Arthropathy |
4.6% |
| Pustular Psoriasis |
4.4% |
| Off Label Use |
4.2% |
| Prostate Cancer |
4.2% |
| Weight Decreased |
4.0% |
| Headache |
3.8% |
| Death |
3.8% |
| Herpes Zoster |
3.4% |
| Drug Ineffective |
3.4% |
| Weight Increased |
3.0% |
| Tuberculosis |
3.0% |
| Breast Cancer |
2.5% |
| Hepatic Enzyme Increased |
2.4% |
| Hepatic Function Abnormal |
2.4% |
| Liver Function Test Abnormal |
2.4% |
|
| Secondary |
| Psoriasis |
73.1% |
| Product Used For Unknown Indication |
7.9% |
| Psoriatic Arthropathy |
6.4% |
| Hypertension |
2.5% |
| Prophylaxis |
1.9% |
| Crohn's Disease |
1.9% |
| Diabetes Mellitus |
1.0% |
| Ill-defined Disorder |
0.9% |
| Pustular Psoriasis |
0.8% |
| Depression |
0.6% |
| Hyperlipidaemia |
0.5% |
| Pain |
0.4% |
| Folliculitis |
0.4% |
| Anticoagulant Therapy |
0.3% |
| Convulsion Prophylaxis |
0.2% |
| Hyperuricaemia |
0.2% |
| Asthma |
0.2% |
| Hypothyroidism |
0.2% |
| Contraception |
0.2% |
| Hidradenitis |
0.2% |
|
| Psoriasis |
20.6% |
| Hepatic Function Abnormal |
8.7% |
| Cellulitis |
6.7% |
| Myocardial Infarction |
6.2% |
| Pneumonia |
5.7% |
| Drug Ineffective |
4.9% |
| Off Label Use |
4.9% |
| Psoriatic Arthropathy |
4.9% |
| Cerebrovascular Accident |
3.9% |
| Neck Pain |
3.9% |
| Weight Decreased |
3.7% |
| Liver Disorder |
3.6% |
| Syncope |
3.1% |
| Nasopharyngitis |
2.9% |
| Type 2 Diabetes Mellitus |
2.9% |
| Gamma-glutamyltransferase Increased |
2.8% |
| Condition Aggravated |
2.7% |
| Gastroenteritis |
2.7% |
| Liver Function Test Abnormal |
2.7% |
| Staphylococcal Infection |
2.6% |
|
| Concomitant |
| Psoriasis |
51.9% |
| Product Used For Unknown Indication |
13.3% |
| Psoriatic Arthropathy |
10.5% |
| Anxiety |
4.6% |
| Depression |
3.9% |
| Crohn's Disease |
2.8% |
| Post Concussion Syndrome |
2.6% |
| Prophylaxis |
1.5% |
| Pain |
1.1% |
| Rheumatoid Arthritis |
1.1% |
| Vitamin Supplementation |
1.1% |
| Hypertension |
0.9% |
| Post-traumatic Pain |
0.9% |
| Thyroid Disorder |
0.9% |
| Hypersensitivity |
0.7% |
| Parkinson's Disease |
0.7% |
| Acute Psychosis |
0.4% |
| Dyspepsia |
0.4% |
| Hypothyroidism |
0.4% |
| Low Density Lipoprotein Increased |
0.4% |
|
| Psoriasis |
37.7% |
| Drug Ineffective |
20.3% |
| Therapeutic Response Decreased |
9.4% |
| Skin Plaque |
4.3% |
| Pancreatic Carcinoma |
2.9% |
| Pancreatitis |
2.9% |
| Psoriatic Arthropathy |
2.9% |
| Weight Decreased |
2.2% |
| Acute Psychosis |
1.4% |
| Arthritis |
1.4% |
| Crohn's Disease |
1.4% |
| Drug Interaction |
1.4% |
| Gastrointestinal Haemorrhage |
1.4% |
| Headache |
1.4% |
| Hypertension |
1.4% |
| Injection Site Pain |
1.4% |
| Prostate Cancer |
1.4% |
| Pyrexia |
1.4% |
| Rash |
1.4% |
| Skin Exfoliation |
1.4% |
|
| Interacting |
| Psoriasis |
90.0% |
| Hyperlipidaemia |
10.0% |
|
| Psoriasis |
57.1% |
| Ataxia |
14.3% |
| Drug Level Increased |
14.3% |
| Myalgia |
14.3% |
|
